Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Prader-Willi Syndrome (PWS) is a rare genetic disorder present at birth that results in several physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In most cases, there is a deletion. In remaining cases, the entire chromosome from the father is missing and there are instead two chromosome 15s from the mother (uniparental disomy). Symptoms include poor muscle tone, low levels of sex hormones, and a constant feeling of hunger.
The Prader-Willi Syndrome drugs in development market research report provide comprehensive information on the therapeutics under development for Prader-Willi Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Prader-Willi Syndrome and features dormant and discontinued projects.
Key Targets in the Prader-Willi Syndrome Pipeline Products Market
The key targets in the Prader-Willi Syndrome pipeline products market are Oxytocin Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Gastric Inhibitory Polypeptide, Growth Hormone Secretagogue Receptor Type 1, Histamine H3 Receptor, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 2A, and others.
Prader-Willi Syndrome Pipeline Products Analysis Market by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the Prader-Willi Syndrome Pipeline Products Market
The key mechanisms of action in the Prader-Willi Syndrome pipeline products market are Oxytocin Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 1 Antagonist, Cannabinoid Receptor 2 Agonist, Histamine H3 Receptor Antagonist, Sodium Dependent Dopamine Transporter Inhibitor, Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2C Agonist, and others.
Prader-Willi Syndrome Pipeline Products Market Analysis by Mechanism of Actions
For more mechanism of actions insights, download a free report sample
Key Routes of Administration in the Prader-Willi Syndrome Pipeline Products Market
The key routes of administration in the Prader-Willi Syndrome pipeline products market are oral, nasal, intramuscular, intrathecal, parenteral, and topical.
Prader-Willi Syndrome Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the Prader-Willi Syndrome Pipeline Products Market
The key molecule types in the Prader-Willi Syndrome pipeline products market are small molecule, synthetic peptide, biologic, monoclonal antibody, and RNAi gene therapy.
Prader-Willi Syndrome Pipeline Products Market Analysis by Molecule Type
For more molecule type insights, download a free report sample
Major Companies in the Prader-Willi Syndrome Pipeline Products Market
Some of the major companies in the Prader-Willi Syndrome pipeline products market are Benuvia Therapeutics Inc, 9 Meters Biopharma Inc, Aardvark Therapeutics Inc, Altamira Therapeutics Ltd, Beryl Therapeutics Inc, Biomind Labs Inc, Bioprojet SCR, Carmot Therapeutics Inc, ConSynance Therapeutics Inc, and Ferring International Center SA.
Prader-Willi Syndrome Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
Market Report Overview
Key targets | Oxytocin Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Gastric Inhibitory Polypeptide, Growth Hormone Secretagogue Receptor Type 1, Histamine H3 Receptor, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 2A, and Others |
Key mechanism of action | Oxytocin Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 1 Antagonist, Cannabinoid Receptor 2 Agonist, Histamine H3 Receptor Antagonist, Sodium Dependent Dopamine Transporter Inhibitor, Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2C Agonist, and Others |
Key routes of administration | Oral, Nasal, Intramuscular, Intrathecal, Parenteral, and Topical |
Key molecule type | Small Molecule, Synthetic Peptide, Biologic, Monoclonal Antibody, and RNAi Gene Therapy |
Major companies | Benuvia Therapeutics Inc, 9 Meters Biopharma Inc, Aardvark Therapeutics Inc, Altamira Therapeutics Ltd, Beryl Therapeutics Inc, Biomind Labs Inc, Bioprojet SCR, Carmot Therapeutics Inc, ConSynance Therapeutics Inc, and Ferring International Center SA |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Prader-Willi Syndrome (PWS) (Genetic Disorders).
- The pipeline guide reviews pipeline therapeutics for Prader-Willi Syndrome (PWS) (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Prader-Willi Syndrome (PWS) (Genetic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Prader-Willi Syndrome (PWS) (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Prader-Willi Syndrome (PWS) (Genetic Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Prader-Willi Syndrome (PWS) (Genetic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Aardvark Therapeutics Inc
Altamira Therapeutics Ltd
Benuvia Therapeutics Inc
Beryl Therapeutics Inc
Biomind Labs Inc
Bioprojet SCR
Carmot Therapeutics Inc
ConSynance Therapeutics Inc
Ferring International Center SA
GLWL Research Inc
Helsinn Group
Inversago Pharma Inc
Lipidio Pharmaceuticals Inc
Lumos Pharma Inc
Neuracle Science Co Ltd
Neuren Pharmaceuticals Ltd
Notitia Biotechnologies Co
OptiNose Inc
OT4B
Saniona AB
Soleno Therapeutics Inc
Taysha Gene Therapies Inc
Tonix Pharmaceuticals Holding Corp
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Prader-Willi Syndrome products market?
The key targets in the Prader-Willi Syndrome pipeline products market are Oxytocin Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Gastric Inhibitory Polypeptide, Growth Hormone Secretagogue Receptor Type 1, Histamine H3 Receptor, Sodium Dependent Dopamine Transporter, Sodium Dependent Noradrenaline Transporter, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 2A, and others.
-
What are the key mechanisms of action in the Prader-Willi Syndrome pipeline products market?
The key mechanisms of action in the Prader-Willi Syndrome pipeline products market are Oxytocin Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 1 Antagonist, Cannabinoid Receptor 2 Agonist, Histamine H3 Receptor Antagonist, Sodium Dependent Dopamine Transporter Inhibitor, Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2C Agonist, and others.
-
What are the key routes of administration in the Prader-Willi Syndrome pipeline products market?
The key routes of administration in the Prader-Willi Syndrome pipeline products market are oral, nasal, intramuscular, intrathecal, parenteral, and topical.
-
What are the key molecule types in the Prader-Willi Syndrome pipeline products market?
The key molecule types in the Prader-Willi Syndrome pipeline products market are small molecule, synthetic peptide, biologic, monoclonal antibody, and RNAi gene therapy.
-
Which are the major companies in the Prader-Willi Syndrome pipeline products market?
Some of the major companies in the Prader-Willi Syndrome pipeline products market are Benuvia Therapeutics Inc, 9 Meters Biopharma Inc, Aardvark Therapeutics Inc, Altamira Therapeutics Ltd, Beryl Therapeutics Inc, Biomind Labs Inc, Bioprojet SCR, Carmot Therapeutics Inc, ConSynance Therapeutics Inc, and Ferring International Center SA.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.